Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma

  • Authors:
    • Eiji Iwata
    • Takumi Hasegawa
    • Daisuke Takeda
    • Takeshi Ueha
    • Teruya Kawamoto
    • Toshihiro Akisue
    • Yoshitada Sakai
    • Takahide Komori
  • View Affiliations

  • Published online on: February 5, 2016     https://doi.org/10.3892/ijo.2016.3380
  • Pages: 1493-1498
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Oral squamous cell carcinoma (OSCC) is the most common form of oral cancers. Recent studies have shown that the malignant transformation of various carcinomas, including OSCC, is associated with epithelial-mesenchymal transition (EMT), and that expression of the EMT factors are significantly associated with tumor invasion, tumor metastasis, and survival rates in OSCC patients. Hence, there is a possibility that EMT suppression may improve the prognosis of OSCC patients. Hypoxia inducible factor-1α (HIF-1α) is a crucial microenvironmental factor in tumor progression, which induces the expression of EMT factors. We previously reported that transcutaneous CO2 suppresses both human OSCC tumor growth and metastasis to the regional lymph nodes by improving hypoxia in treated tissue. According to this background, we hypothesized that increased EMT with HIF-1α expression may increase the progression and the metastatic potential of OSCC, and that decreased hypoxia by transcutaneous CO2 could suppress EMT. In the present study, in vitro studies showed that hypoxic conditions increased the expression of HIF-1α and EMT factors in OSCC cells. In addition, in vivo studies revealed that transcutaneous CO2 increased E-cadherin expression with the decreased expression of HIF-1α, Snail, Slug, N-cadherin, and Vimentin in tumor treatment. These results suggest that transcutaneous CO2 could suppress EMT by improving hypoxia, resulting in the reduction of metastatic potential of OSCC. The findings indicate that transcutaneous CO2 may be able to improve the prognosis of OSCC patients through the suppression of EMT.
View Figures
View References

Related Articles

Journal Cover

April 2016
Volume 48 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Iwata, E., Hasegawa, T., Takeda, D., Ueha, T., Kawamoto, T., Akisue, T. ... Komori, T. (2016). Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma. International Journal of Oncology, 48, 1493-1498. https://doi.org/10.3892/ijo.2016.3380
MLA
Iwata, E., Hasegawa, T., Takeda, D., Ueha, T., Kawamoto, T., Akisue, T., Sakai, Y., Komori, T."Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma". International Journal of Oncology 48.4 (2016): 1493-1498.
Chicago
Iwata, E., Hasegawa, T., Takeda, D., Ueha, T., Kawamoto, T., Akisue, T., Sakai, Y., Komori, T."Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma". International Journal of Oncology 48, no. 4 (2016): 1493-1498. https://doi.org/10.3892/ijo.2016.3380